Ir para o conteúdo principal

United States Technology

Grafa
Technology

Revvity to exit China Immunodiagnostics business as Q1 sales beat estimates

Revvity (NYSE:RVTY) exceeded Wall Street estimates for the first quarter and unveiled a major strategic pivot, announcing its intention to divest its China Immunodiagnostics business to sharpen its focus on high-growth life sciences and specialty diagnostics.

Leia mais: Revvity to exit China Immunodiagnostics business as Q1 sales beat estimates